An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses. Lobigs M, Pavy M, Hall RA, Lobigs P, Cooper P, Komiya T, Toriniwa H, Petrovsky N. J Gen Virol. 2010 Jun;91(Pt 6):1407-17. Epub 2010 Feb 3.PMID:20130134  Free full text Related citations

Challenges in improving influenza vaccine protection in the elderly. Petrovsky N, Ross TM. Expert Rev Vaccines. 2011 Jan;10(1):7-11. PMID: 21162614 Free ArticleInduction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. Cristillo AD, Ferrari MG, Hudacik L, Lewis B, Galmin L, Bowen B, Thompson D, Petrovsky N, Markham P, Pal R. J Gen Virol. 2011 Jan;92(Pt 1):128-40. PMID: 21169215 Related citations

AFCo1, a meningococcal B-derived cochleate adjuvant, strongly enhances antibody and T-cell immunity against Plasmodium falciparum merozoite surface protein 4 and 5. Bracho G, Zayas C, Wang L, Coppel R, Pérez O, Petrovsky N. Malar J. 2009 Feb 27;8:35. PMID: 19250541 Free PMC Article

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity. Petrovsky N. Vaccine. 2006 Apr 12;24 Suppl 2:S2-26-9. Review. PMID: 16823913 Free full text Related citations

Information technologies for vaccine research. Brusic V, August JT, Petrovsky N. Expert Rev Vaccines. 2005 Jun;4(3):407-17. Review. PMID: 16026252  Related citations